You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Drugs in MeSH Category Adjuvants, Immunologic


✉ Email this page to a colleague

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharma ERGAMISOL levamisole hydrochloride TABLET;ORAL 020035-001 Jun 18, 1990 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz GLATOPA glatiramer acetate INJECTABLE;SUBCUTANEOUS 206921-001 Feb 12, 2018 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Synthon Pharms Inc GLATIRAMER ACETATE glatiramer acetate INJECTABLE;SUBCUTANEOUS 203857-001 Sep 25, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz GLATOPA glatiramer acetate INJECTABLE;SUBCUTANEOUS 090218-001 Apr 16, 2015 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.